![]() |
||||||||||||||
|
![]() |
|||||||||||||
Our Services specialized animal models
Available murine models of Alzheimer’s disease rely solely upon the super normal expression of amyloid precursor protein (APP) which is not predictive of the human condition. In addition, available models exhibit exponential plaque deposition kinetics which may confound efforts to identify drug candidate efficacy. Melior’s proprietary huAβ mouse model is capable of reliably and predictably assessing plaque deposition relevant to the progression of human Alzheimer’s disease. Melior’s neuroTRACEdg platform provides the addition of Melior Discovery’s complementary behavioral models, so that improvement of cognitive deficits in Alzheimer’s disease can be effectively evaluated. Melior's theraTRACE® discovery platform includes over 35 standardized and
* Amyloid Plaque Deposition - Exclusive Model
|
||||||||||||||